Stem Cell Therapeutic and Research Reauthorization Act of 2025
119-hr5160 — Stem Cell Therapeutic and Research Reauthorization Act of 2025. Sponsored by Rep. Smith, Christopher H. [R-NJ-4]. Introduced 2025-09-04. House bill. 119th Congress. Latest action: Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
Bill Activity
House
Introduced in House
2025-09-04
Introduced
2025-09-04
Introduced in House
Reported from Committee
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
Committee
2025-09-04
Referred to the Subcommittee on Health.
Committee
2026-05-13
Forwarded by Subcommittee to Full Committee by Voice Vote.
Committee
2026-05-21
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
- Sponsor
- Rep. Smith, Christopher H. [R-NJ-4] (R), NJ
- Introduced
- 2025-09-04
- Committees
- Energy and Commerce Committee
- Subjects
- Biological and life sciences; Blood and blood diseases; Cell biology and embryology; Health programs administration and funding; Organ and tissue donation and transplantation
- Latest Action
- Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
No roll-call vote data available for this bill.
Explore This Bill
Investigate this bill → AI summary, roll-call breakdown, and full bill analysis